Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

DelMar Pharmaceuticals Inc. (DMPI)

0.578   -0.062 (-9.62%) 02-21 15:59
Open: 0.6532 Pre. Close: 0.6395
High: 0.6532 Low: 0.57
Volume: 243,068 Market Cap: 7M
DelMar Pharmaceuticals Inc is a clinical stage drug development company. It is engaged in research and development of cancer indications.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.651 - 0.654 0.654 - 0.658
Low: 0.562 - 0.566 0.566 - 0.569
Close: 0.575 - 0.581 0.581 - 0.586

Technical analysis

as of: 2020-02-21 4:29:19 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.73     One year: 0.82
Support: Support1: 0.50    Support2: 0.42
Resistance: Resistance1: 0.63    Resistance2: 0.70
Pivot: 0.55
Moving Average: MA(5): 0.58     MA(20): 0.55
MA(100): 0.60     MA(250): 1.59
MACD: MACD(12,26):     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 51.34     %D(3): 41.57
RSI: RSI(14): 50.98
52-week: High: 6.29  Low: 0.40  Change(%): -81.9
Average Vol(K): 3-Month: 36282  10-Days: 23496

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
DMPI has closed below upper band by 27.1%. Bollinger Bands are 49.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to DMPI's normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 29 Jan 2020 20:41:26 +0000
Health Care Sector Update for 01/29/2020: DMPI,BHVN,CNAT,HEPA

Thu, 27 Jun 2019 12:41:54 +0000
Health Care Sector Update for 06/27/2019: DMPI

Wed, 31 Jul 2019 19:50:40 +0000
Health Care Sector Update for 07/31/2019: DMPI,NUVA,AMGN,ACRS

Thu, 25 Jul 2019 01:59:29 +0000
6 Top Gainers In Healthcare Sector (GHDX, THC, IART…)

Mon, 03 Jun 2019 18:38:56 +0000
Mid-Afternoon Market Update: NASDAQ Down 1.5%; Genocea Biosciences Shares Spike Higher

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 11.40
Shares Float (M) 10.05
% Held by Insiders 6.28
% Held by Institutions 11.35
Shares Short (K) 560
Shares Short P. Month (K)

Stock Financials

EPS -1.984
Book Value (p.s.) 0.190
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -76.5
Return on Equity (ttm) -143.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.703
Qtrly Earnings Growth
Operating Cash Flow (M) -6.51
Levered Free Cash Flow (M) -3.38

Stock Valuations

P/E -0.29
P/E Growth Ratio -0.10
P/BV 3.04
P/CF -1.01

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-05-07
Last Split Ratio 0.1
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.